Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arthroscopic knee surgery

This article was originally published in The Gray Sheet

Executive Summary

Report submitted to CMS by the American Academy of Orthopedic Surgeons lists indicators for which the procedure is deemed "reasonable and necessary" for the osteoarthritic knee, including x-ray of no or minimal degenerative arthritis, normal alignment or minimal malalignment and mechanical symptoms such as locking, catching and buckling. The agency met with AAOS Jan. 30 to discuss the report, which could support a national coverage decision (NCD) for arthroscopic knee surgery in osteoarthritic knees. CMS expects to make a decision on the NCD by April 7...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel